222 related articles for article (PubMed ID: 29764588)
1. [Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients].
Guo L; Ding G; Xu W; Ge H; Jiang Y; Lu Y
Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):383-388. PubMed ID: 29764588
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of serum Ape1/Ref-1 combined with TGF-β1 monitoring in predicting the occurrence of radiation pneumonitis (RP) in non-small cell lung cancer patients.
Zhang Y; You H; Duan J; Gao Y
Ann Palliat Med; 2021 Mar; 10(3):3328-3335. PubMed ID: 33849117
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
[TBL] [Abstract][Full Text] [Related]
4. Prognostic biological factors of radiation pneumonitis after stereotactic body radiation therapy combined with pulmonary perfusion imaging.
Guo L; Ding G; Xu W; Lu Y; Ge H; Jiang Y; Chen X; Li Y
Exp Ther Med; 2019 Jan; 17(1):244-250. PubMed ID: 30651789
[TBL] [Abstract][Full Text] [Related]
5. APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.
Shin JH; Choi S; Lee YR; Park MS; Na YG; Irani K; Lee SD; Park JB; Kim JM; Lim JS; Jeon BH
Cancer Res Treat; 2015 Oct; 47(4):823-33. PubMed ID: 25672588
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503
[TBL] [Abstract][Full Text] [Related]
7. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis.
Arpin D; Perol D; Blay JY; Falchero L; Claude L; Vuillermoz-Blas S; Martel-Lafay I; Ginestet C; Alberti L; Nosov D; Etienne-Mastroianni B; Cottin V; Perol M; Guerin JC; Cordier JF; Carrie C
J Clin Oncol; 2005 Dec; 23(34):8748-56. PubMed ID: 16314635
[TBL] [Abstract][Full Text] [Related]
8. Radiation pneumonitis in patients with non--small-cell lung cancer treated with erlotinib concurrent with thoracic radiotherapy.
Zhuang H; Yuan Z; Chang JY; Wang J; Pang Q; Zhao L; Wang P
J Thorac Oncol; 2014 Jun; 9(6):882-5. PubMed ID: 24828665
[TBL] [Abstract][Full Text] [Related]
9. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells.
Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D
Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133
[TBL] [Abstract][Full Text] [Related]
10. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
Zhang S; He L; Dai N; Guan W; Shan J; Yang X; Zhong Z; Qing Y; Jin F; Chen C; Yang Y; Wang H; Baugh L; Tell G; Wilson DM; Li M; Wang D
Oncotarget; 2016 Nov; 7(47):77482-77494. PubMed ID: 27813497
[TBL] [Abstract][Full Text] [Related]
11. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
12. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
13. Genistein alleviates radiation-induced pneumonitis by depressing Ape1/Ref-1 expression to down-regulate inflammatory cytokines.
Liu GD; Xia L; Zhu JW; Ou S; Li MX; He Y; Luo W; Li J; Zhou Q; Yang XQ; Shan JL; Wang G; Wang D; Yang ZZ
Cell Biochem Biophys; 2014 Jul; 69(3):725-33. PubMed ID: 24659138
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
Antonadou D
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
[TBL] [Abstract][Full Text] [Related]
15. Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI).
Harada H; Seto T; Igawa S; Tsuya A; Wada M; Kaira K; Naito T; Hayakawa K; Nishimura T; Masuda N; Yamamoto N
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1777-82. PubMed ID: 21621337
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
[TBL] [Abstract][Full Text] [Related]
17. Incidence and Risk Factors of Symptomatic Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy and Consolidation Durvalumab.
Shintani T; Kishi N; Matsuo Y; Ogura M; Mitsuyoshi T; Araki N; Fujii K; Okumura S; Nakamatsu K; Kishi T; Atsuta T; Sakamoto T; Narabayashi M; Ishida Y; Sakamoto M; Fujishiro S; Katagiri T; Kim YH; Mizowaki T
Clin Lung Cancer; 2021 Sep; 22(5):401-410. PubMed ID: 33678582
[TBL] [Abstract][Full Text] [Related]
18. Cytokine plasma levels: reliable predictors for radiation pneumonitis?
Rübe CE; Palm J; Erren M; Fleckenstein J; König J; Remberger K; Rübe C
PLoS One; 2008 Aug; 3(8):e2898. PubMed ID: 18682839
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
Lee YH; Choi HS; Jeong H; Kang KM; Song JH; Lee WS; Lee GW; Song HN; Kim HG; Kang MH; Rhee DY; Jeong BK
Clin Respir J; 2018 Mar; 12(3):1264-1273. PubMed ID: 28618180
[TBL] [Abstract][Full Text] [Related]
20. Temporal and spatial dose distribution of radiation pneumonitis after concurrent radiochemotherapy in stage III non-small cell cancer patients.
Alharbi M; Janssen S; Golpon H; Bremer M; Henkenberens C
Radiat Oncol; 2017 Nov; 12(1):165. PubMed ID: 29096667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
